STAAR Surgical Share Holder Equity 2010-2023 | STAA
STAAR Surgical share holder equity from 2010 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
STAAR Surgical Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$386 |
| 2022 |
$336 |
| 2021 |
$259 |
| 2020 |
$197 |
| 2019 |
$160 |
| 2018 |
$132 |
| 2017 |
$43 |
| 2016 |
$38 |
| 2015 |
$39 |
| 2014 |
$37 |
| 2013 |
$39 |
| 2012 |
$32 |
| 2011 |
$29 |
| 2010 |
$22 |
| 2009 |
$21 |
STAAR Surgical Quarterly Share Holder Equity
(Millions of US $) |
| 2023-12-31 |
$386 |
| 2023-09-30 |
$379 |
| 2023-06-30 |
$354 |
| 2023-03-31 |
$339 |
| 2022-12-31 |
$336 |
| 2022-09-30 |
$320 |
| 2022-06-30 |
$299 |
| 2022-03-31 |
$276 |
| 2021-12-31 |
$259 |
| 2021-09-30 |
$249 |
| 2021-06-30 |
$235 |
| 2021-03-31 |
$214 |
| 2020-12-31 |
$197 |
| 2020-09-30 |
$186 |
| 2020-06-30 |
$175 |
| 2020-03-31 |
$165 |
| 2019-12-31 |
$160 |
| 2019-09-30 |
$149 |
| 2019-06-30 |
$144 |
| 2019-03-31 |
$137 |
| 2018-12-31 |
$132 |
| 2018-09-30 |
$129 |
| 2018-06-30 |
$51 |
| 2018-03-31 |
$46 |
| 2017-12-31 |
$43 |
| 2017-09-30 |
$41 |
| 2017-06-30 |
$38 |
| 2017-03-31 |
$37 |
| 2016-12-31 |
$38 |
| 2016-09-30 |
$38 |
| 2016-06-30 |
$38 |
| 2016-03-31 |
$38 |
| 2015-12-31 |
$39 |
| 2015-09-30 |
$40 |
| 2015-06-30 |
$40 |
| 2015-03-31 |
$36 |
| 2014-12-31 |
$37 |
| 2014-09-30 |
$41 |
| 2014-06-30 |
$42 |
| 2014-03-31 |
$41 |
| 2013-12-31 |
$39 |
| 2013-09-30 |
$38 |
| 2013-06-30 |
$35 |
| 2013-03-31 |
$33 |
| 2012-12-31 |
$32 |
| 2012-09-30 |
$33 |
| 2012-06-30 |
$31 |
| 2012-03-31 |
$31 |
| 2011-12-31 |
$29 |
| 2011-09-30 |
$28 |
| 2011-06-30 |
$26 |
| 2011-03-31 |
$23 |
| 2010-12-31 |
$22 |
| 2010-09-30 |
$22 |
| 2010-06-30 |
$22 |
| 2010-03-31 |
$23 |
| 2009-12-31 |
$21 |
| 2009-09-30 |
$22 |
| 2009-06-30 |
$23 |
| 2009-03-31 |
$14 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.355B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
